-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
BridgeBio Pharma, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q2 2021 to Q4 2024.
- BridgeBio Pharma, Inc. Earnings Per Share, Basic for the quarter ending December 31, 2024 was -1.43 USD/shares, a 47.4% decline year-over-year.
- BridgeBio Pharma, Inc. Earnings Per Share, Basic for the twelve months ending December 31, 2024 was -2.88 USD/shares, a 27.1% increase year-over-year.
- BridgeBio Pharma, Inc. annual Earnings Per Share, Basic for 2024 was -2.88 USD/shares, a 27.1% increase from 2023.
- BridgeBio Pharma, Inc. annual Earnings Per Share, Basic for 2023 was -3.95 USD/shares, a 21.2% decline from 2022.
- BridgeBio Pharma, Inc. annual Earnings Per Share, Basic for 2022 was -3.26 USD/shares, a 16.4% increase from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)